Sign up to save your podcasts
Or
Share A Feasbility Evaluating the Use of Home OCT for a Clinical Trial of Faricimab Treatment of nAMD
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A Feasbility Evaluating the Use of Home OCT for a Clinical Trial of Faricimab Treatment of nAMD
We discuss the feasibility of using home OCT vs. a treat and extend approach in a clinical trial of faricimab in neovascular AMD with Dr. Kevin Blinder of the Retina Institute in Saint Louis, Mo and Profesor of Ophthalmology at Washington University School of Medicine.
View all episodes
By Retina Synthesis
4.5
88 ratings
We discuss the feasibility of using home OCT vs. a treat and extend approach in a clinical trial of faricimab in neovascular AMD with Dr. Kevin Blinder of the Retina Institute in Saint Louis, Mo and Profesor of Ophthalmology at Washington University School of Medicine.
More shows like Retina Synthesis
View all
New Retina Radio by Eyetube
18 Listeners
White Coat Investor Podcast
2,445 Listeners
The Daily
112,683 Listeners
WSJ Minute Briefing
670 Listeners
Up First from NPR
56,469 Listeners
Bogleheads On Investing Podcast
595 Listeners
MedEdTalks - Ophthalmology
4 Listeners
American Journal of Ophthalmology Podcasts Collection
11 Listeners
Experts InSight
52 Listeners
RETINA Journal Podcasts
10 Listeners
Ophthalmology Journal
18 Listeners
Talking Euretina
1 Listeners
RetinaRounds™
0 Listeners
The Last Invention
708 Listeners